- Home
- ABEO vs SATL Comparison
ABEO vs SATL Comparison
Compare ABEO & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SATL
- Stock Information
- Founded
- ABEO 1974
- SATL 2010
- Country
- ABEO United States
- SATL United States
- Employees
- ABEO N/A
- SATL N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- ABEO Health Care
- SATL Technology
- Exchange
- ABEO Nasdaq
- SATL Nasdaq
- Market Cap
- ABEO 332.0M
- SATL 351.9M
- IPO Year
- ABEO 1980
- SATL N/A
- Fundamental
- Price
- ABEO $6.26
- SATL $3.43
- Analyst Decision
- ABEO Strong Buy
- SATL
- Analyst Count
- ABEO 6
- SATL 0
- Target Price
- ABEO $18.00
- SATL N/A
- AVG Volume (30 Days)
- ABEO 611.9K
- SATL 1.1M
- Earning Date
- ABEO 08-19-2025
- SATL 08-18-2025
- Dividend Yield
- ABEO N/A
- SATL N/A
- EPS Growth
- ABEO N/A
- SATL N/A
- EPS
- ABEO N/A
- SATL N/A
- Revenue
- ABEO N/A
- SATL $12,929,000.00
- Revenue This Year
- ABEO N/A
- SATL N/A
- Revenue Next Year
- ABEO $322.37
- SATL N/A
- P/E Ratio
- ABEO N/A
- SATL N/A
- Revenue Growth
- ABEO N/A
- SATL 9.47
- 52 Week Low
- ABEO $3.93
- SATL $0.87
- 52 Week High
- ABEO $7.32
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- ABEO 47.50
- SATL 48.29
- Support Level
- ABEO $6.18
- SATL $3.15
- Resistance Level
- ABEO $6.94
- SATL $3.55
- Average True Range (ATR)
- ABEO 0.27
- SATL 0.18
- MACD
- ABEO -0.05
- SATL 0.00
- Stochastic Oscillator
- ABEO 18.07
- SATL 45.16
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.